Showing posts with label India. Show all posts
Showing posts with label India. Show all posts

Thursday, 9 July 2020

ED addresses Congress pioneer Ahmed Patel for fourth time in PMLA case

ED addresses Congress pioneer Ahmed Patel for fourth time in PMLA case 

Ahmed Patel (70) was last addressed regarding the case on July 2 for around 10 hours. He had told correspondents that the ED specialists had suggested 128 conversation starters to him more than three meetings. 

congress senior leader ahmed patel


ED sleuths started the fourth round of addressing of senior Congress pioneer Ahmed Patel at his official living arrangement here on Thursday regarding the Sandesara siblings' bank misrepresentation and illegal tax avoidance case, authorities said. 

A three-part group of the government test organization arrived at the Rajya Sabha MP's 23, Mother Teresa Crescent living arrangement in the Lutyens' zone of focal Delhi around 11 am. 

Patel (70) was last addressed regarding the case on July 2 for around 10 hours. He had told correspondents that the ED examiners had suggested 128 conversation starters to him more than three meetings. 

Read More:
"This is political grudge and badgering against me and my family and I don't know under whose tension they (examiners) are working," Patel had said. The Congress party treasurer has confronted ED examining for concerning 27 hours till now during meetings hung on June 27, June 30 and July 2. 


Patel was permitted to be tested at home after he wouldn't visit the Enforcement Directorate (ED) office, refering to the predominant COVID-19 rules that debilitate senior residents from going out. 

The authorities said the Congress chief's announcement is being recorded under the Prevention of Money Laundering Act (PMLA). 


He is being examined concerning his indicated joins with the Sandesara siblings, advertisers of the Vadodara-based Sterling Biotech pharmaceutical organization, and affirmed dealings of his relatives with them. 

The office had scrutinized Patel's child Faisal and child in-law Irfan Ahmed Siddiqui regarding the case and recorded their announcements a year ago. 

The two were addressed with regards to the announcement of one Sunil Yadav, a worker of the Sandesara gathering, which was recorded before the organization. 


In his announcement to the ED, Yadav had said he bore the "costs of Rs 10 lakh" for a gathering which was gone to by Faisal, "masterminded" passage into a dance club for him and once conveyed "Rs 5 lakh" to his driver in Delhi's Khan Market on the directions of Chetan Sandesara, one of the advertisers of Sterling Biotech, sources had said. 

He had told the organization that the money was "intended for Faisal Patel", the sources had said. 

The ED was likewise told by Yadav that Siddiqui "involved" a house in Delhi's Vasant Vihar, which purportedly had a place with Chetan Sandesara


The illegal tax avoidance case relates to the supposed Rs 14,500-crore bank-credit extortion, said to have been executed by Sterling Biotech and its primary advertisers and executives - Nitin Jayantilal Sandesara, Chetankumar Jayantilal Sandesara and Deepti Sandesara - every one of whom are slipping off. 

Nitin and Chetankumar are siblings. 

The ED has affirmed this is a greater bank trick in volume than the Punjab National Bank (PNB) extortion including criminal diamantaires Nirav Modi and Mehul Choksi

The sum engaged with the PNB case is pegged at about Rs 13,400 crore. 

The Sandesaras are additionally confronting separate tests by the Central Bureau of Investigation (CBI) and Income-Tax division for their supposed nexus with prominent government officials and charges of defilement and tax avoidance individually. 


At present, the Sandesaras are expressed to be situated in Albania in Europe. Endeavors are on to remove them. 

The ED enlisted a criminal case regarding the supposed bank-advance extortion based on a FIR and a chargesheet documented by the CBI. 


It is affirmed that the organization took advances of over Rs 5,383 crore from a residential consortium drove by the Andhra Bank, which later transformed into non-performing resources, and the ED has claimed that the advertisers laundered the cash utilizing shell or questionable firms.

Monday, 6 July 2020

Boosting Immunity Against COVID Tripura Style! Appropriate Vitamin-C Rich Fruits Like Pineapple

Boosting Immunity Against COVID Tripura Style! Appropriate Vitamin-C Rich Fruits Like Pineapple 


The COVID-19 pandemic is not normal for anything that we have seen so far in an exceptionally significant time-frame. What's more, since the infection isn't disappearing at any point in the near future and the antibody will take as much time as is needed to be advertise prepared, all the better we can do is to make an effort not to get the infection. 

vitamin c fruits for improving immunity against corona virus (Covid-19)


One approach to do it is by improving our resistance and there are a few medications, home cures, and practices like yoga that can help in this. Be that as it may, in the northeastern territory of Tripura, the legislature is evaluating a novel methodology. 


Tripura Chief Minister Biplab Kumar Deb has said that the state government will begin free dispersion of nutrient C improved natural products among individuals in urban regions from Saturday to support their invulnerabilities to battle the coronavirus contamination. 

The legislature has just allotted Rs 1 crore for the ''Mukhya Mantri Corona Pratirodhak Abhiyan''. "The state government will begin appropriating nutrient C improved organic products particularly pineapple and lemon from July 4. 


"These organic products have been purchased legitimately from the ranchers so they could likewise get benefits. The plan will be checked by the National Urban Livelihood Mission at the grassroots," Deb said in a Facebook post. 

The natural products will be disseminated by urban neighborhood bodies all through the express every Saturday from 12 pm to 4 pm. 


"The essential thought behind the program is to frustrate the disease of Covid-19 by boosting individuals' resistance," state's Law and Education Minister Ratan Lal Nath said. Tripura produces 1.28 lakh huge amounts of pineapples yearly. The sovereign assortment of pineapple is the state foods grown from the ground to Dubai, Bangladesh and numerous different nations. 

Read more:
"The state cultivation division has given a rundown of pineapple and lemon developing spots and names of ranchers to the specialists concerned with the goal that they could purchase and gracefully these natural products," an authority said. 


In contrast to most of the northeastern states, Tripura has seen a similarly high number of COVID-19 cases. The state has so far recorded an saggregate of 1,401 COVID-19 case. Be that as it may, a sum of 1,093 COVID-19 patients have so far recouped from the disease. 

What is significantly progressively great is the COVID-19 death rate in Tripura. The state has so far recorded only one demise from the viral disease.

Sunday, 5 July 2020

Here Is Everything We Know About Punjab Basmati Rice Ltd And The Rs 350 Crore Bank Fraud

Here Is Everything We Know About Punjab Basmati Rice Ltd And The Rs 350 Crore Bank Fraud 


After a concise respite, India has been shaken by another bank extortion, indeed running into many crores, and influencing a few banks. The focal point of the extortion is Punjab Basmati Rice Limited, a firm situated in Amritsar, Punjab. 

basmati rice


As per the Central Bureau of Investigation (CBI), the company's executives have duped a few banks to the tune of Rs 350 crores. Manjit Singh Makhni, the chief of Punjab Basmati Rice Ltd had fled the nation toward the start of 2018 and is supposed to be right now living in Canada. 


The CBI, in its FIR, has named different chiefs of Punjab Basmati Rice Ltd, Kulwinder Singh Makhani, Jasmeet Kaur, and obscure bank authorities likewise as blamed for the situation. 

"It was affirmed in the grievance that the denounced had bamboozled the Canara Bank-drove consortium containing Andhra Bank, Union Bank of India, Oriental Bank of Commerce, IDBI Bank, UCO Bank to the tune of Rs 350.84 crore (counting Rs 174.89 crore to the Canara Bank) by arranging off the stock and prime security with no earlier insinuation or endorsement from the consortium loan specialist banks," CBI Spokesperson R.K. Gaur said. 


The FIR was documented in the bamboozling case by the Canara Bank and assault were completed at the premises of Punjab Basmati Rice Limited and its chiefs. The organization had likewise taken a credit of Rs 53 crore from Andhra Bank, Rs 44 crore from UBI, 25 crore from OBC, Rs 14 crore from IDBI and Rs 41 crore from UCO Bank. 

Related Post:
As per the protest by Canara Bank, the firm had money related managing them since 2003 and in 2012 it settled on a consortium plan. The banks included were Andhra Bank, IDBI, OBC, UBI and UCO Bank and the consortium was driven by Canara bank. Inconveniences began in 2018 after the firm neglected to pay the chief sum and intrigue. 


It likewise became known that the firm had discarded the load of rice which was the essential security for the credit without advising the banks. Following this Canara Bank had moved toward the Reserve Bank of India against the defaulting firm. 

The bankruptcy case is right now under the thought of National Company Law Tribunal and Punjab Basmati Rice Ltd is under liquidation.

India's Second COVID-19 Vaccine Gets Approval For Human Trials

India's Second COVID-19 Vaccine Gets Approval For Human Trials 


A test immunization created by the Ahmedabad-based Zydus Cadila Healthcare Ltd for novel coronavirus has now been affirmed for human preliminaries by the Drugs Controller General of India (DCGI)

Zydus, some portion of Ahmedabad-based Cadila Healthcare, got endorsement from the Drugs Controller General of India to lead Phase I and II human clinical preliminaries for its COVID-19 antibody competitor 'ZyCoV-D'. 

Covid-19(Corona Virus) vaccine trials


The potential immunization indicated a "solid safe reaction" in creature considers, and the antibodies delivered had the option to totally kill the wild kind infection, Zydus, some portion of Cadila Healthcare Ltd (CADI.NS), said in an announcement to Indian stock trades. 

India's endorsement for Zydus comes days after secretly held Bharat Biotech got a comparative green light for human investigations for its immunization competitor called Covaxin. 

Related Posts:

Dr V. K.Srinivas ,Vice President, Bharat biotech, taking clinical preliminary of Corona immunization. 

He said that he is the first individual in Quite a while to take immunization created by him and his group. 

Zydus will start human preliminaries this month on more than 1,000 subjects in different destinations in India. The organization additionally plans to increase its creation limit with regards to the immunization competitor to serve Indian and worldwide interest, it included. 


"The organization has submitted information to DCGI dependent on creature preliminary, they directed. Creatures like-mice, bunnies, guinea pigs, rodents were utilized and these creatures created antibodies against the infection," a senior government official was cited as saying by ANI

Their creature preliminary information was reviewed altogether and was discovered agreeable. What's more, presently, DCGI has allowed authorization to Zydus Cadila to lead Phase I and II clinical preliminary for COVID - 19 immunization on people after effective creature preliminary," the authority included. 

No antibody has yet been endorsed for business use against COVID-19, yet in excess of twelve from more than 100 applicants universally are right now being tried in people, and some have indicated potential in beginning phase preliminaries. 


On Tuesday, 30 June, India's first COVID-19 immunization COVAXIN, created by Bharat Biotech International Limited (BBIL) in a joint effort with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) got DCGI gesture to direct Phase I and II human clinical preliminaries. 

Bharat Biotech said preliminaries of the antibody are booked to start across India this month. COVAXIN was created utilizing the SARS-CoV-2 infection strain segregated at NIV, Pune.